Directory › Catalent

Catalent — Philadelphia

Philadelphia, Pennsylvania, United States · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Catalent
Name(s) in FDA data
Catalent Pharma Solutions, LLC
FEI number(s)
3007617094 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Philadelphia, Pennsylvania, United States 19154
Records matched
4 FDA inspections
Most recent FDA inspection in dataset
17 Dec 2025 — NAI

Capabilities (from the company's website)

  • Clinical trial supply & packaging
    …a, United States Our Philadelphia facility is our North American Center of Excellence for clinical supply packaging. Contact Us About This Site View Job Openings Facility at a Glance Service Are…

Taken from the company's web page for this site. Source: https://www.catalent.com/locations/philadelphia-united-states, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 17 Dec 2025
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Human Cellular, Tissue, and Gene Therapies.

    Source: FDA Data Dashboard – Inspections (FEI 3007617094, inspection ID 1297392)

  2. 05 Jun 2025
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3007617094, inspection ID 1275086)

  3. 16 Apr 2019
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3007617094, inspection ID 1089083)

  4. 10 Jun 2014
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3007617094, inspection ID 882445)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.